DGFCX
Price
$29.07
Change
-$0.12 (-0.41%)
Updated
Jun 22 closing price
Net Assets
895.83M
RWIBX
Price
$80.66
Change
-$0.06 (-0.07%)
Updated
Jun 22 closing price
Net Assets
159.53B
Interact to see
Advertisement

DGFCX vs RWIBX

DGFCX vs RWIBX Comparison Chart in %
View a ticker or compare two or three
VS
DGFCX vs. RWIBX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGFCX is a Hold and RWIBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 160B vs. DGFCX (896M). RWIBX pays higher dividends than DGFCX: RWIBX (0.74) vs DGFCX (0.06). DGFCX was incepted earlier than RWIBX: DGFCX (22 years) vs RWIBX (24 years). DGFCX (1.75) is less costly to investors than RWIBX (1.51). RWIBX is a more actively managed with annual turnover of: 44.00 vs. DGFCX (27.00). RWIBX has a lower initial minimum investment than DGFCX: RWIBX (250) vs DGFCX (1000). RWIBX annual gain was more profitable for investors over the last year : 17.83 vs. DGFCX (9.15). RWIBX return over 5 years is better than : 27.84 vs. DGFCX (-5.25).
DGFCXRWIBXDGFCX / RWIBX
Total Expense Ratio1.751.51116%
Annual Report Gross Expense Ratio1.751.51116%
Fund Existence22 years24 years-
Gain YTD-1.49113.017-11%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets896M160B1%
Annual Yield % from dividends0.060.748%
Returns for 1 year9.1517.8351%
Returns for 3 years36.0646.7377%
Returns for 5 years-5.2527.84-19%
Returns for 10 years76.2398.1178%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIPSX44.07N/A
N/A
ProFunds Biotechnology UltraSector Svc
TSVRX22.11N/A
N/A
PGIM Quant Solutions Small-Cap Val R
ACAYX66.15N/A
N/A
Alger Capital Appreciation Instl Y
FIJCX89.83N/A
N/A
Fidelity Advisor Consumer Staples Z
DFIEX22.01-0.42
-1.87%
DFA International Core Equity 2 I